As of 2026-08-24, P3 Health Partners Inc. Common Stock (PIII) has a 3-month relative strength percentile of 17 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 75. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 8.9%, relative volume 0.21×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
PIII is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $87K notional.
Held by 3 ETFs · $152K across latest filings · largest weight 0.00% (IWC).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $87K | — |
| VXFVanguard Extended Market ETF | 0.00% | $40K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PIII Jan avg: -27.21% median: -24.84% win: 0% σ: 13.51% n: 4 2022-04-12 → 2026-07-31 | PIII Feb avg: -1.46% median: -1.10% win: 50% σ: 11.09% n: 4 2022-04-12 → 2026-07-31 | PIII Mar avg: 4.87% median: -6.31% win: 25% σ: 27.48% n: 4 2022-04-12 → 2026-07-31 | PIII Apr avg: -9.86% median: -10.06% win: 40% σ: 26.55% n: 5 2022-04-12 → 2026-07-31 | PIII May avg: 102.67% median: -6.55% win: 40% σ: 166.89% n: 5 2022-04-12 → 2026-07-31 | PIII Jun avg: -17.01% median: -14.75% win: 0% σ: 7.01% n: 5 2022-04-12 → 2026-07-31 | PIII Jul avg: 10.99% median: 17.78% win: 60% σ: 27.71% n: 5 2022-04-12 → 2026-07-31 | PIII Aug avg: -4.56% median: -5.30% win: 50% σ: 13.90% n: 4 2022-04-12 → 2026-07-31 (current) | PIII Sep avg: -11.98% median: -14.78% win: 25% σ: 15.61% n: 4 2022-04-12 → 2026-07-31 | PIII Oct avg: -1.21% median: -2.45% win: 25% σ: 5.99% n: 4 2022-04-12 → 2026-07-31 | PIII Nov avg: -22.04% median: -23.23% win: 0% σ: 15.44% n: 4 2022-04-12 → 2026-07-31 | PIII Dec avg: -22.35% median: -22.69% win: 25% σ: 33.88% n: 4 2022-04-12 → 2026-07-31 |